The American Heart Association and American College of Cardiology have jointly published an updated guideline for managing cardiovascular risks in patients undergoing noncardiac surgery, reflecting a decade of new evidence since the last update in 2014.
Researchers find over 80% of women are iron deficient by their third trimester despite the absence of anaemia in early pregnancy, even in high-resource settings, highlighting the need for improved screening and treatment protocols.
A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.
A single-dose gene therapy has demonstrated significant reduction in bleeding episodes for adults with haemophilia B, potentially offering a long-term solution to this genetic disorder.
New research highlights how small changes in clinicians’ language can affect patient outcomes, from diagnostic accuracy to treatment adherence.
A groundbreaking analysis published in The Lancet predicts a steep rise in deaths from antimicrobial resistance, with older adults most at risk. The study offers a stark reminder of the urgent need for global action to combat this growing threat.
A new book by gerontologist Dr Macie Smith aims to provide essential guidance for those caring for loved ones with dementia. The 60-page resource, titled “A Dementia Caregiver Called to Action: The Journey”, addresses common questions and offers insights throughout the caregiving process.
A new study finds that most cardiovascular devices subject to the most serious recalls by the US FDA lacked rigorous clinical testing before approval, raising concerns about patient safety.
New research reveals how delaying inflammatory signalling can dramatically increase the number of blood stem cells formed during embryonic development, potentially aiding efforts to produce these cells in the laboratory.
Researchers have developed a highly accurate blood test for amyotrophic lateral sclerosis (ALS), potentially reducing diagnosis times and improving patient outcomes.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
© Clyde Campbell